| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Induction by Bacterial Lipopeptides, Lipopolysaccharide, and Imiquimod, but Preserves the Response to R-8481
,
,
* Channing Laboratory, Brigham and Women’s Hospital;
Infectious Diseases, Children’s Hospital; and
Harvard Medical School, Boston, MA 02115; and
Department of Immunology, Genentech, South San Francisco, CA 94080
Newborns are at increased risk of overwhelming infection, yet the mechanisms underlying this susceptibility are incompletely defined. In this study we report a striking 1- to 3-log decrease in sensitivity of monocytes in human neonatal cord blood, compared with monocytes in adult peripheral blood, to the TNF-
-inducing effect of multiple TLR ligands, including bacterial lipopeptides (BLPs), LPS, and the imidazoquinoline compound, imiquimod. In marked contrast, TNF- release in response to R-848, a TLR ligand that is a congener of imiquimod, was equivalent in newborn and adult blood. Differences in ligand-induced TNF- release correlated with divergent ligand-induced changes in monocyte TNF- mRNA levels. Newborn and adult monocytes did not differ in basal mRNA or protein expression of TLRs or mRNA expression of functionally related molecules. Newborn monocytes demonstrated diminished LPS-induced, but equivalent R-848-induced, phosphorylation of p38 mitogen-activated protein kinase and altered BLP- and LPS-induced acute modulation of cognate receptors, suggesting that the mechanism accounting for the observed differences may be localized proximal to ligand recognition by surface TLRs. Remarkably, newborn plasma conferred substantially reduced BLP-, LPS-, and imiquimod-induced TNF- release on adult monocytes without any effect on R-848-induced TNF- release, reflecting differences in a plasma factor(s) distinct from soluble CD14. Impaired response to multiple TLR ligands may significantly contribute to immature neonatal immunity. Conversely, relative preservation of responses to R-848 may present unique opportunities for augmenting innate and acquired immunity in the human newborn.
This article has been cited by other articles:
|
|
 |
|
  B. W. Kramer, S. G. Kallapur, T. J. Moss, I. Nitsos, J. P. Newnham, and A. H. Jobe Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep Innate Immunity, April 1, 2009; 15(2): 101 - 107. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Larange, D. Antonios, M. Pallardy, and S. Kerdine-Romer TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation J. Leukoc. Biol., April 1, 2009; 85(4): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wynn, P. O. Scumpia, R. D. Winfield, M. J. Delano, K. Kelly-Scumpia, T. Barker, R. Ungaro, O. Levy, and L. L. Moldawer Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists Blood, September 1, 2008; 112(5): 1750 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhao, K. D. Kim, X. Yang, S. Auh, Y.-X. Fu, and H. Tang From the Cover: Hyper innate responses in neonates lead to increased morbidity and mortality after infection PNAS, May 27, 2008; 105(21): 7528 - 7533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Marshall, D. S. Heeke, M. L. Gesner, B. Livingston, and G. Van Nest Negative regulation of TLR9-mediated IFN-{alpha} induction by a small-molecule, synthetic TLR7 ligand J. Leukoc. Biol., September 1, 2007; 82(3): 497 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chelvarajan, D. Popa, Y. Liu, T. V. Getchell, A. J. Stromberg, and S. Bondada Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages J. Leukoc. Biol., August 1, 2007; 82(2): 403 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Walker and D. R. Goldstein Neonatal B Cells Suppress Innate Toll-Like Receptor Immune Responses and Modulate Alloimmunity J. Immunol., August 1, 2007; 179(3): 1700 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, E. Deriaud, X. Jiao, D. Braun, C. Leclerc, and R. Lo-Man Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells J. Exp. Med., May 14, 2007; 204(5): 1107 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Echeverry, K. Schesser, and B. Adkins Murine Neonates Are Highly Resistant to Yersinia enterocolitica following Orogastric Exposure Infect. Immun., May 1, 2007; 75(5): 2234 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aksoy, V. Albarani, M. Nguyen, J.-F. Laes, J.-L. Ruelle, D. De Wit, F. Willems, M. Goldman, and S. Goriely Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells Blood, April 1, 2007; 109(7): 2887 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pierrot, E. Adam, D. Hot, S. Lafitte, M. Capron, J. D. George, and J. Khalife Contribution of T Cells and Neutrophils in Protection of Young Susceptible Rats from Fatal Experimental Malaria J. Immunol., February 1, 2007; 178(3): 1713 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gibbard, P. J. Morley, and N. J. Gay Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling J. Biol. Chem., September 15, 2006; 281(37): 27503 - 27511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levy, E. E. Suter, R. L. Miller, and M. R. Wessels Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells Blood, August 15, 2006; 108(4): 1284 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levy, M. Coughlin, B. N. Cronstein, R. M. Roy, A. Desai, and M. R. Wessels The Adenosine System Selectively Inhibits TLR-Mediated TNF-{alpha} Production in the Human Newborn J. Immunol., August 1, 2006; 177(3): 1956 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Henneke and R. Berner Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect. Immun., June 1, 2006; 74(6): 3085 - 3095. [Full Text] [PDF]
|
|
|
|
|
|
L. Marodi Neonatal Innate Immunity to Infectious Agents Infect. Immun., April 1, 2006; 74(4): 1999 - 2006. [Full Text] [PDF]
|
|
|
|
|
|
E. LeBouder, J. E. Rey-Nores, A.-C. Raby, M. Affolter, K. Vidal, C. A. Thornton, and M. O. Labeta Modulation of Neonatal Microbial Recognition: TLR-Mediated Innate Immune Responses Are Specifically and Differentially Modulated by Human Milk J. Immunol., March 15, 2006; 176(6): 3742 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schlaepfer, A. Audige, H. Joller, and R. F. Speck TLR7/8 Triggering Exerts Opposing Effects in Acute versus Latent HIV Infection. J. Immunol., March 1, 2006; 176(5): 2888 - 2895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Deering and J. S. Orange Development of a Clinical Assay To Evaluate Toll-Like Receptor Function Clin. Vaccine Immunol., January 1, 2006; 13(1): 68 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gunzer, H. Riemann, Y. Basoglu, A. Hillmer, C. Weishaupt, S. Balkow, B. Benninghoff, B. Ernst, M. Steinert, T. Scholzen, et al. Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion Blood, October 1, 2005; 106(7): 2424 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levy Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists Innate Immunity, April 1, 2005; 11(2): 113 - 116. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
